ASP Isotopes Inc

NASDAQ:ASPIUnited States

parties; and the competitive nature of our industry. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. This press release includes market and industry data and forecasts that we obtained from internal research, publicly available information and industry publications and surveys. Industry publications and surveys generally state that the information contained therein has been obtained from sources believed to be reliable. Unless otherwise noted, statements as to our potential market position relative to other companies are approximated and based on third-party data and internal analysis and estimates as of the date of this press release. We have not independently verified this information, and it could prove inaccurate. Industry and market data could be wrong because of the method by which sources obtained their data and because information cannot always be verified with certainty due to the limits on the availability and reliability of raw data, the voluntary nature of the data-gathering process and other limitations and uncertainties. In addition, we do not know all of the assumptions regarding general economic conditions or growth that were used in preparing the information and forecasts from sources cited herein. No information in this press release should be interpreted as an indication of future success, revenues, results of operation, or stock price. All forward-looking statements herein are qualified by reference to the cautionary statements set forth herein and should not be relied upon.

ASP Isotopes Inc. enters into Memorandum of Understanding with the South African Nuclear Energy Corporation (Necsa) to collaborate on the research, development and construction of an Advanced Nuclear Fuel Production Facility

ASP Isotopes Announces Closing of Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares

WASHINGTON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company") today announced the closing of the previously announced underwritten public offering of shares of its common stock. ASP Isotopes sold 2,754,250 shares of its common stock, which reflects the exercise in full by the underwriter of its option to purchase up to 359,250 additional shares of common stock, at a public offering price of $6.75 per share, less underwriting discounts and commissions. The total gross proceeds to ASP Isotopes from the offering (before deducting the underwriting discounts and commissions and offering expenses) were $18.6 million.